These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9588864)
1. Rationale for the use of immunotoxins in the treatment of HIV-infected humans. Van Oijen MG; Preijers FW J Drug Target; 1998; 5(2):75-91. PubMed ID: 9588864 [TBL] [Abstract][Full Text] [Related]
2. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells. Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249 [TBL] [Abstract][Full Text] [Related]
3. In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein. Pincus SH; Cole RL; Hersh EM; Lake D; Masuho Y; Durda PJ; McClure J J Immunol; 1991 Jun; 146(12):4315-24. PubMed ID: 1710247 [TBL] [Abstract][Full Text] [Related]
4. Immunoconjugates that neutralize HIV virions kill T cells infected with diverse strains of HIV-1. Kim YW; Fung MS; Sun NC; Sun CR; Chang NT; Chang TW J Immunol; 1990 Feb; 144(4):1257-62. PubMed ID: 2303707 [TBL] [Abstract][Full Text] [Related]
5. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis? Herbeuval JP; Shearer GM AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946 [TBL] [Abstract][Full Text] [Related]
6. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells. Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567 [TBL] [Abstract][Full Text] [Related]
7. CD4 activation of HIV fusion. Sattentau QJ Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein. Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111 [TBL] [Abstract][Full Text] [Related]
9. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo. Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694 [TBL] [Abstract][Full Text] [Related]
10. Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein. Chaudhary VK; Mizukami T; Fuerst TR; FitzGerald DJ; Moss B; Pastan I; Berger EA Nature; 1988 Sep; 335(6188):369-72. PubMed ID: 2843774 [TBL] [Abstract][Full Text] [Related]
11. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection. Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies. Zarling JM; Moran PA; Haffar O; Sias J; Richman DD; Spina CA; Myers DE; Kuebelbeck V; Ledbetter JA; Uckun FM Nature; 1990 Sep; 347(6288):92-5. PubMed ID: 1975641 [TBL] [Abstract][Full Text] [Related]
13. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S; Houston LL Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765 [TBL] [Abstract][Full Text] [Related]
14. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120. Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755 [TBL] [Abstract][Full Text] [Related]
15. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499 [TBL] [Abstract][Full Text] [Related]
16. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies. Ahmad A; Ladha A; Cohen EA; Menezes J Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893 [TBL] [Abstract][Full Text] [Related]
17. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Landau NR; Warton M; Littman DR Nature; 1988 Jul; 334(6178):159-62. PubMed ID: 3260352 [TBL] [Abstract][Full Text] [Related]
18. Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding. Schnittman SM; Lane HC; Roth J; Burrows A; Folks TM; Kehrl JH; Koenig S; Berman P; Fauci AS J Immunol; 1988 Dec; 141(12):4181-6. PubMed ID: 3264307 [TBL] [Abstract][Full Text] [Related]
19. Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site. Chamat S; Nara P; Berquist L; Whalley A; Morrow WJ; Köhler H; Kang CY J Immunol; 1992 Jul; 149(2):649-54. PubMed ID: 1378074 [TBL] [Abstract][Full Text] [Related]
20. In vivo efficacy of anti-glycoprotein 41, but not anti-glycoprotein 120, immunotoxins in a mouse model of HIV infection. Pincus SH; Fang H; Wilkinson RA; Marcotte TK; Robinson JE; Olson WC J Immunol; 2003 Feb; 170(4):2236-41. PubMed ID: 12574398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]